341 related articles for article (PubMed ID: 18376417)
21. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
Kniess A; Ziegler E; Thieme D; Müller RK
J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
[TBL] [Abstract][Full Text] [Related]
22. Quantification of insulin-like growth factor-1 in dried blood spots for detection of growth hormone abuse in sport.
Cox HD; Rampton J; Eichner D
Anal Bioanal Chem; 2013 Feb; 405(6):1949-58. PubMed ID: 23263515
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone in sport: beyond Beijing 2008.
Segura J; Gutiérrez-Gallego R; Ventura R; Pascual JA; Bosch J; Such-Sanmartín G; Nikolovski Z; Pinyot A; Pichini S
Ther Drug Monit; 2009 Feb; 31(1):3-13. PubMed ID: 19155963
[TBL] [Abstract][Full Text] [Related]
24. The Use and Abuse of Human Growth Hormone in Sports.
Siebert DM; Rao AL
Sports Health; 2018; 10(5):419-426. PubMed ID: 29932857
[TBL] [Abstract][Full Text] [Related]
25. The Use and Abuse of Growth Hormone in Sports.
Holt RIG; Ho KKY
Endocr Rev; 2019 Aug; 40(4):1163-1185. PubMed ID: 31180479
[TBL] [Abstract][Full Text] [Related]
26. Insulin, growth hormone and sport.
Sonksen PH
J Endocrinol; 2001 Jul; 170(1):13-25. PubMed ID: 11431133
[TBL] [Abstract][Full Text] [Related]
27. Growth Hormone and Insulin-Like Growth Factor-1.
Nicholls AR; Holt RI
Front Horm Res; 2016; 47():101-14. PubMed ID: 27347885
[TBL] [Abstract][Full Text] [Related]
28. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
29. Use of hormones in doping and cancer risk.
De Santi M; Baldelli G; Brandi G; ;
Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
[TBL] [Abstract][Full Text] [Related]
30. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes.
Karila T; Koistinen H; Seppälä M; Koistinen R; Seppälä T
Clin Endocrinol (Oxf); 1998 Oct; 49(4):459-63. PubMed ID: 9876343
[TBL] [Abstract][Full Text] [Related]
31. New detection methods of growth hormone and growth factors.
Bidlingmaier M
Endocr Dev; 2012; 23():52-9. PubMed ID: 23182820
[TBL] [Abstract][Full Text] [Related]
32. [Identification of candidate genes and expression profiles, as doping biomarkers].
Paparini A; Impagnatiello F; Pistilli A; Rinaldi M; Gianfranceschi G; Signori E; Stabile AM; Fazio V; Rende M; Romano Spica V
Ann Ig; 2007; 19(4):303-14. PubMed ID: 17937323
[TBL] [Abstract][Full Text] [Related]
33. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI
Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534
[TBL] [Abstract][Full Text] [Related]
34. Is human growth hormone an ergogenic aid?
Holt RI
Drug Test Anal; 2009 Sep; 1(9-10):412-8. PubMed ID: 20355223
[TBL] [Abstract][Full Text] [Related]
35. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.
Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH
J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001
[TBL] [Abstract][Full Text] [Related]
36. GH & IGF Research issue on doping with growth hormone.
Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):283-4. PubMed ID: 19535276
[No Abstract] [Full Text] [Related]
37. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes.
Erotokritou-Mulligan I; Bassett EE; Bartlett C; Cowan D; McHugh C; Seah R; Curtis B; Wells V; Harrison K; Sönksen PH; Holt RI;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2760-3. PubMed ID: 18413420
[TBL] [Abstract][Full Text] [Related]
38. The development of decision limits for the implementation of the GH-2000 detection methodology using current commercial insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
Erotokritou-Mulligan I; Guha N; Stow M; Bassett EE; Bartlett C; Cowan DA; Sönksen PH; Holt RI
Growth Horm IGF Res; 2012 Apr; 22(2):53-8. PubMed ID: 22305721
[TBL] [Abstract][Full Text] [Related]
39. Detection of growth hormone responsive proteins using SELDI-TOF mass spectrometry.
Chung L; Baxter RC
Growth Horm IGF Res; 2009 Aug; 19(4):383-7. PubMed ID: 19467616
[TBL] [Abstract][Full Text] [Related]
40. Statistical methodology for age-adjustment of the GH-2000 score detecting growth hormone misuse.
Böhning D; Böhning W; Guha N; Cowan DA; Sönksen PH; Holt RI
BMC Med Res Methodol; 2016 Oct; 16(1):147. PubMed ID: 27793179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
